Click here to Download this video

To download video: Right click on the following button and select "Save Link As"

WSJ journalist John Carreyrou shares year-long Theranos investigation & breaks latest, stunning news

This Week in Startups

Subscribers 0 subscribers


Share with Link:
Published on Jan 28, 2016
Wall Street Journal's John Carreyrou started reporting on Theranos nearly a year ago, since uncovering a multitude of troubling facts about the fast-rising startup amid a firestorm of controversy. In October 2015, John informed the public about the co's struggles with its blood-testing tech. This week, it's the Centers for Medicare and Medicaid Services (CMS) findings that Theranos lab poses an immediate risk to patient health. And today, in an exclusive interview, John breaks the news that Walgreens is suspending use of a CA Theranos lab and closing its Wellness Center, effective immediately. Jason and John dive into the details of the Theranos story, starting from John's initial tip about something amiss through today's stunning developments. We learn exactly why CMS considers Theranos to be a public health threat; how Chief Scientific Officer Ian Gibbons, before he took his own life, told his wife that nothing at Theranos was working; John being repeatedly ignored on requests to interview Founder Elizabeth Holmes; insights on his reporting and the WSJ vetting process; the dangers of bringing a healthcare product too soon to market; when, if ever, this story will end -- and much more.

Never miss an episode!

Subscribe in iTunes: Audio ( || Video (

Find us on Spotify Now.

Thanks to our sponsors. Click here to tweet your support (can edit before sending):

InVision. Find out why so many hot startups are using InVision to prototype, present & collaborate on design in real-time. Sign-up for a 90-day free trial today at:

Wistia. Video marketing tools for business with great analytics. Start your 2-week free trial today, no credit card required.


Follow on Twitter:

Launch Festival:
Special thanks to the members of the TWiST Backchannel!
Support TWiST and join the Backchannel:
Up next